A new FDA story? Fill in the blanks.

Why even bother having an FDA reporter when writing an FDA “expose” story is as easy as, well, Mad Libs.

New Report by (proper noun) Accuses FDA of (adjective) Oversight

Today (adjective) Citizens for (adjective) Health, a not-for-profit organization, released a (adjective) meta-analysis that (adverb) concludes the FDA, “is in the (noun) of (adjective) Pharma.”

“Our research of (number) concerned (plural noun) points (adverb) to an agency that has once again (verb past tense) the American public. It’s a (adjective) indication that the FDA places (noun) over (noun) and cannot be trusted to (verb) or (verb) – and certainly not (verb) in the public interest,” said the author’s report Dr. Sidney (type of animal).

“I find this new report both (adjective) and (adjective) – but (adverb) not (adjective),” commented Representative Henry (proper name).” “And I intend to hold televised (plural noun) on the matter.”

“This is just another (adjective) example of the FDA’s lack of (adjective) (noun), added Dr. Steven (name of automobile company). If I were the FDA Commissioner this (adjective) circumstance would never have occurred.”

In an embargoed editorial, the New (place name) Journal of Medicine opined that the (adjective) problem “is caused by the Prescription (noun) User-Fee Act and made even (adjective) by the agency’s continued (verb) of direct to (noun) advertising.” The editorial also points to the need for (adjective) importation of prescription (plural noun) from (name of country).

Supporting this notion, the AAR(letter) added that (adverb) high (plural noun) for drugs are a result of the (type of shrub) Administration's (adjective) program known as Part (letter) and supports (adjective) government (verb).

The FDA had (adjective) comment.